Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1792 News Items found High-Fructose Diet Harms Neurodevelopment and Leads to Anxiety in Mice, MSK Study Finds Wednesday, June 11, 2025 A new laboratory study from MSK is shedding light on the mechanisms by which high fructose consumption early in life may directly impact brain development and increase the risk of anxiety disorders later on. Researchers Develop New AI Tool To Improve Blood Cancer Diagnosis Wednesday, June 11, 2025 Learn more about DeepHeme, an artificial intelligence tool that helps doctors to diagnose blood and bone marrow cancers. 2024 MSK Giving Friday, June 6, 2025 In 2024, the MSK Giving community raised $511 million to advance MSK’s mission of ending cancer for life — every single dollar donated is making a real difference in the way we treat and understand cancer. A Love Story and a Legacy at MSK Friday, June 6, 2025 Tom Scalera and Brett Ravage found a second chance at love through the MSK community after losing their spouses to cancer in 2019. Together, they have raised more than $10 million for cancer research. A Message From the Chairman and President Friday, June 6, 2025 Learn from the MSK President/CEO and Chair of the Board of Trustees about some of the most important advances in cancer care and science at MSK in 2024. Dedicated to Serving the Underserved: Margaret Bediones Friday, June 6, 2025 Meet MSK Clinical Nurse Margaret Bediones of MSK's Ralph Lauren Center in Harlem: “I love talking to people to educate them about the importance of cancer prevention and screening.” How a Better Understanding of Metastasis May Lead to Better Cancer Treatment Friday, June 6, 2025 Metastasis is responsible for about 9 of every 10 cancer deaths, and it remains one of the most daunting and least understood aspects of the disease. Researchers across MSK are approaching a wide variety of metastatic cancer types from many directions. Keeping Spirits Up: Chaplain Yusuf Hasan Friday, June 6, 2025 Meet MSK Chaplain Yusuf Hasan: “I get a great blessing from sitting at the bedside of the sickest of the sick and making sure to see them as human beings, not just an illness.” Living With Stage 4 Cancer Friday, June 6, 2025 For those living with advanced cancer, quality of life means pursuing what matters most to each person — whether that’s making art, running marathons, caring for others, or spending more time with family. MSK Research Lead to FDA Approval for Cancer Drugs in 2024 Friday, June 6, 2025 The U.S. Food and Drug Administration (FDA) approved 11 cancer drugs in 2024 based on significant contributions from MSK researchers. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer